National Cost Of Revenue vs Net Income Analysis
NHC Stock | USD 122.49 0.36 0.29% |
National HealthCare financial indicator trend analysis is infinitely more than just investigating National HealthCare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether National HealthCare is a good investment. Please check the relationship between National HealthCare Cost Of Revenue and its Net Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.
Cost Of Revenue vs Net Income
Cost Of Revenue vs Net Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of National HealthCare Cost Of Revenue account and Net Income. At this time, the significance of the direction appears to have weak relationship.
The correlation between National HealthCare's Cost Of Revenue and Net Income is 0.34. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income in the same time period over historical financial statements of National HealthCare, assuming nothing else is changed. The correlation between historical values of National HealthCare's Cost Of Revenue and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of National HealthCare are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Cost Of Revenue i.e., National HealthCare's Cost Of Revenue and Net Income go up and down completely randomly.
Correlation Coefficient | 0.34 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Cost Of Revenue
Cost of Revenue is found on National HealthCare income statement and represents the costs associated with goods and services National HealthCare provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in National HealthCare financial statement analysis. It represents the amount of money remaining after all of National HealthCare operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most indicators from National HealthCare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into National HealthCare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.At present, National HealthCare's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 1.3 B, whereas Selling General Administrative is forecasted to decline to about 39.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 344.9M | 388.1M | 429.2M | 333.8M | Total Revenue | 1.0B | 1.1B | 1.1B | 710.2M |
National HealthCare fundamental ratios Correlations
Click cells to compare fundamentals
National HealthCare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National HealthCare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.3B | 1.4B | 1.4B | 1.3B | 1.3B | 772.0M | |
Short Long Term Debt Total | 232.0M | 194.0M | 166.7M | 125.9M | 93.4M | 76.8M | |
Other Current Liab | 15.0M | 200.4M | 176.2M | 112.8M | 134.9M | 72.8M | |
Total Current Liabilities | 194.8M | 281.2M | 263.2M | 197.9M | 214.5M | 165.7M | |
Total Stockholder Equity | 778.6M | 795.2M | 903.0M | 874.3M | 908.8M | 954.2M | |
Property Plant And Equipment Net | 535.4M | 520.3M | 521.0M | 627.1M | 587.5M | 349.6M | |
Net Debt | 29.3M | 46.9M | 59.0M | 67.3M | (13.7M) | (13.0M) | |
Accounts Payable | 18.9M | 21.1M | 22.5M | 17.0M | 19.2M | 14.7M | |
Cash | 202.8M | 147.1M | 107.6M | 58.7M | 107.1M | 68.6M | |
Non Current Assets Total | 945.6M | 905.4M | 976.8M | 921.5M | 904.6M | 499.2M | |
Non Currrent Assets Other | 410.2M | 385.1M | 455.8M | 106.2M | 125.4M | 110.8M | |
Cash And Short Term Investments | 202.8M | 323.4M | 256.0M | 182.6M | 223.6M | 131.1M | |
Net Receivables | 97.2M | 90.6M | 96.6M | 100.3M | 109.0M | 78.1M | |
Common Stock Shares Outstanding | 15.4M | 15.4M | 15.4M | 15.4M | 15.4M | 14.1M | |
Liabilities And Stockholders Equity | 1.3B | 1.4B | 1.4B | 1.3B | 1.3B | 772.0M | |
Non Current Liabilities Total | 313.3M | 285.7M | 237.2M | 200.0M | 185.8M | 156.3M | |
Inventory | 7.4M | 8.8M | 8.6M | 7.1M | 7.4M | 6.4M | |
Other Current Assets | 183.0M | 33.9M | 7.4M | 64.0M | 66.2M | 76.5M | |
Other Stockholder Equity | (330.3M) | 226.9M | 232.2M | 227.0M | 227.6M | 134.4M | |
Total Liab | 508.1M | 567.0M | 500.4M | 397.9M | 400.3M | 321.9M | |
Property Plant And Equipment Gross | 738.3M | 699.4M | 1.1B | 506.5M | 1.2B | 1.3B | |
Total Current Assets | 341.1M | 456.8M | 426.6M | 353.9M | 406.2M | 272.8M | |
Accumulated Other Comprehensive Income | 2.6M | 5.1M | 1.6M | (9.5M) | (6.6M) | (6.3M) | |
Short Term Debt | 38.4M | 59.7M | 64.5M | 68.1M | 60.4M | 46.7M | |
Retained Earnings | 553.1M | 563.0M | 669.1M | 656.7M | 687.6M | 722.0M | |
Short Term Investments | 152.5M | 176.4M | 148.4M | 123.9M | 116.5M | 114.8M | |
Other Liab | 119.2M | 285.7M | 237.2M | 108.2M | 124.4M | 89.4M | |
Other Assets | 147.1M | 385.1M | 455.8M | 117.1M | 134.6M | 114.1M | |
Property Plant Equipment | 535.4M | 520.3M | 521.0M | 506.5M | 582.5M | 403.6M | |
Current Deferred Revenue | 122.4M | 67.3M | 24.5M | 10.9M | (60.8M) | (57.7M) | |
Noncontrolling Interest In Consolidated Entity | 476K | 3.1M | 5.5M | 3.2M | 3.7M | 3.9M | |
Retained Earnings Total Equity | 553.1M | 563.0M | 669.1M | 656.7M | 755.2M | 448.2M | |
Net Tangible Assets | 778.6M | 795.2M | 903.0M | 874.3M | 1.0B | 815.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.021 | Dividend Share 2.4 | Earnings Share 7.99 | Revenue Per Share 79.613 | Quarterly Revenue Growth 0.179 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.